Madrigal Pharmaceuticals (MDGL) Asset Utilization Ratio (2011 - 2026)
Madrigal Pharmaceuticals (MDGL) posted quarterly Asset Utilization Ratio of 1.04 for Q2 2026, up 102.7% year-over-year from 0.51 in Q2 2025, and up 14.06% quarter-over-quarter from 0.91 in Q1 2026.
Powered by 
Analysis
Madrigal Pharmaceuticals (MDGL) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has reported Asset Utilization Ratio for 6 consecutive years, with 1.04 the latest figure, recorded in Q2 2026.
- In Q2 2026, Asset Utilization Ratio rose 102.7% year-over-year to 1.04; the TTM figure through Jun 2026 stood at 1.04 (up 102.7% YoY), while the FY2025 annual figure was 0.83, up 288.97% from the prior year.
- Asset Utilization Ratio improved to 1.04 in Q2 2026 per MDGL's latest filing, from 0.91 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 1.04 in Q2 2026 and bottomed at 0.01 in Q2 2024.
- Historically, Asset Utilization Ratio has averaged 0.49 across 3 years, with a median of 0.51 in 2025.
- Annual changes were most pronounced in 2025 — Asset Utilization Ratio soared 3719.66% — and 2026, when it surged 102.7%.
- Madrigal Pharmaceuticals' Asset Utilization Ratio stood at 0.17 in 2024, then soared by 329.27% to 0.73 in 2025, then jumped by 42.1% to 1.04 in 2026.
- Business Quant data shows MDGL's Asset Utilization Ratio at 1.04 in Q2 2026, 0.91 in Q1 2026, and 0.73 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 0.20 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 0.69 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 0.90 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.13 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 0.54 |
| 10 | Madrigal Pharmaceuticals | 15.79 Bn | 14.96 Bn | - | 1.04 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.04 |
| Mar 31, 2026 | 0.91 |
| Dec 31, 2025 | 0.73 |
| Sep 30, 2025 | 0.62 |
| Jun 30, 2025 | 0.51 |
| Mar 31, 2025 | 0.31 |
| Dec 31, 2024 | 0.17 |
| Sep 30, 2024 | 0.07 |
| Jun 30, 2024 | 0.01 |
| Dec 31, 2013 | 0.00 |
| Sep 30, 2013 | 0.00 |
| Jun 30, 2013 | 0.01 |
| Sep 30, 2012 | 0.07 |
| Jun 30, 2012 | 0.10 |
| Mar 31, 2012 | 0.13 |
| Dec 31, 2011 | 0.16 |
| Sep 30, 2011 | 0.14 |